Dyslipidemia
Learn about the latest trends, discover events and innovations in the changing world of dyslipidemia disease.
Science in Dyslipidemia Disease
Get a 360º view and stay up-to-date on cardiovascular disease with content selected for you
Cardiovascular diseases (CVDs) are the leading cause of death globally1
According to the World Health Organization, an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths1. Of these deaths, 85% were due to myocardial infarction or stroke1.
A CV event is a highly traumatic experience for patients and their families2. It takes a heavy emotional toll, brings widespread disability and significantly impedes quality of life3,4.
Acute LDL-C Reduction Post ACS: Strike Early and Strike Strong: From Evidence to Clinical Practice
Inspiration and innovation
Get inspired and stay at the forefront of innovation with the following resources
Acute LDL-C Reduction Post ACS: Strike Early and Strike Strong: From Evidence to Clinical Practice
-from-the-SAFEHEART-registry.png/jcr:content/Clinical%20practice%20experience%20in%20patients%20with%20familial%20hypercholesterolemia%20(FH)%20from%20the%20SAFEHEART%20registry.png)
Clinical practice experience in patients with familial hypercholesterolemia (FH) from the SAFEHEART registry
Proprotein convertase subtilisin/kexin type 9 inhibitors for heterozygous familial hypercholesterolemia: A clinical practice experience from the SAFEHEART registry
Events
Stay up to date and register for the latest events and view webinar recordings.
.jpg/jcr:content/image%20(5).jpg)
VTE Safety Zone: Prof. Juan Arcelus - Primary VTE Prophylaxis in Patients with Cancer Undergoing Major Abdominal/Pelvic Surgery
VTE Safety Zone: VTE in general surgery from risk assessment to appropriate thromboprophylaxis
